Section Arrow
CVM.NYSE-M
- Cel-Sci Corp
Quotes are at least 15-min delayed:2026/02/02 07:50 EST
Pre Market
Last
 5.8
0 (0.00%)
Bid
5.47
Ask
5.85
High 5.8 
Low 5.8 
Volume 20 
Regular Hours (Closed)
Last
 5.8
-0.07 (-1.19%)
Day High 
6.0148 
Prev. Close
5.87 
1-M High
6.75 
Volume 
82.77K 
Bid
5.47
Ask
5.85
Day Low
5.43 
Open
5.94 
1-M Low
4.9 
Market Cap 
49.36M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.78 
20-SMA 5.65 
50-SMA 5.9 
52-W High 20.409 
52-W Low 0.1912 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-6.27/-5.40
Enterprise Value
56.30M
Balance Sheet
Book Value Per Share
1.90
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
APREAprea Therapeutics0.796+0.206+34.92%0.42PE
Pre Market 0.6894 -0.1066 -13.39%
VIVSVivoSim Lab Inc2.92+1.22+71.76%5.78PE
Pre Market 2.76 -0.16 -5.48%
GUTSFractyl Health0.46-0.1249-21.35%-- 
Pre Market 0.4922 +0.0322 +7.00%
QNCXQuince Therapeutics0.17-0.1001-37.06%-- 
Pre Market 0.1631 -0.0069 -4.06%
IBRXImmunityBio6.25+0.34+5.75%-- 
Pre Market 6.35 +0.1 +1.60%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.